The Enterprise Value as of November 2024 (TTM) for OncoCyte Corporation (OCX) is 43.40M

According to OncoCyte Corporation’s latest financial reports and current stock price. The company's current Enterprise Value is 43.40M. This represents a change of 106.92% compared to the average of 20.98M of the last 4 quarters.

OncoCyte Corporation (OCX) Historical Enterprise Value (quarterly & annually)

How has OCX Enterprise Value performed in the past?

The mean historical Enterprise Value of OncoCyte Corporation over the last ten years is 99.28M. The current 43.40M Enterprise Value has changed 4.27% with respect to the historical average. Over the past ten years (40 quarters), OCX's Enterprise Value was at its highest in in the June 2021 quarter at 475.41M. The Enterprise Value was at its lowest in in the June 2023 quarter at -12372300.00.

OncoCyte Corporation (OCX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of OncoCyte Corporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

OncoCyte Corporation (OCX) Average Enterprise Value

How has OCX Enterprise Value performed in the past?

The current Enterprise Value of OncoCyte Corporation (OCX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

OncoCyte Corporation (OCX) Enterprise Value vs. Peers

How is OCX’s Enterprise Value compared to its peers?

OncoCyte Corporation’s Enterprise Value is greater than Burning Rock Biotech Limited (-221014826.69), less than Neuronetics, Inc. (53.17M), greater than DarioHealth Corp. (35.79M), greater than Genetron Holdings Limited (-48977790.00), less than Sera Prognostics, Inc. (254.22M), less than Olink Holding AB (publ) (3.16B), less than FONAR Corporation (81.28M), less than Castle Biosciences, Inc. (853.55M), greater than Exagen Inc. (41.38M), less than Personalis, Inc. (266.95M), greater than Interpace Biosciences, Inc. (17.12M), greater than iSpecimen Inc. (1.93M), less than Trinity Biotech plc (106.78M), greater than Intelligent Bio Solutions Inc. (729.52K), less than Biodesix, Inc. (238.15M), greater than Precipio, Inc. (9.10M), less than ProPhase Labs, Inc. (65.47M), less than Sotera Health Company (6.58B),

Build a custom stock screener for OncoCyte Corporation (OCX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like OncoCyte Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

OncoCyte Corporation (OCX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like OncoCyte Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.